statistiche ricercatore

PAROLARO, DANIELA

Distribuzione geografica

Continente	#
NA - Nord America	11333
EU - Europa	3869
AS - Asia	1410
SA - Sud America	16
Continente sconosciuto - Info sul continente non disponibili	15
OC - Oceania	3
AF - Africa	2
Totale	16648

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	11296
UA - Ucraina	1450
SE - Svezia	760
TR - Turchia	611
IT - Italia	541
VN - Vietnam	420
CN - Cina	360
FI - Finlandia	349
DE - Germania	257
IE - Irlanda	185
GB - Regno Unito	155
FR - Francia	93
CA - Canada	34
BE - Belgio	33
EU - Europa	15
NL - Olanda	10
BR - Brasile	6
ES - Italia	6
RU - Federazione Russa	6
DK - Danimarca	5
CL - Cile	4
IN - India	4
CH - Svizzera	3
CO - Colombia	3
JP - Giappone	3
MY - Malesia	3
AR - Argentina	2
AU - Australia	2
BG - Bulgaria	2
GR - Grecia	2
IL - Israele	2
LT - Lituania	2
MX - Messico	2
PT - Portogallo	2
AE - Emirati Arabi Uniti	1
CZ - Repubblica Ceca	1
EC - Ecuador	1
EG - Egitto	1
ID - Indonesia	1
IR - Iran	1
LA - Repubblica Popolare Democratica del Laos	1
LI - Liechtenstein	1
LU - Lussemburgo	1
MA - Marocco	1
MD - Moldavia	1
MM - Myanmar	1
MN - Mongolia	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PA - Panama	1
PL - Polonia	1
RO - Romania	1
SG - Singapore	1
SK - Slovacchia (Repubblica Slovacca)	1
Totale	16648

Salva come PNG Salva come JPEG

Città	#
Fairfield	1834
Woodbridge	1128
Jacksonville	1099
Chandler	1089
Houston	827
Seattle	750
Ashburn	743
Wilmington	728
Ann Arbor	659
Cambridge	607
Dearborn	393
Princeton	380
Izmir	352
Nyköping	349
Dong Ket	218
Como	189
Dublin	184
San Mateo	161
San Diego	88
Beijing	69
Milan	66
Hefei	48
Kunming	42
Norwalk	38
Nanjing	34
Brussels	33
Rome	28
Toronto	26
London	23
Ponte Lambro	23
Boardman	21
Nanchang	19
Verona	19
Guangzhou	18
Mcallen	18
Redwood City	18
Kocaeli	17
Düsseldorf	16
Fuzhou	14
Falls Church	13
Jinan	13
Carbonara Al Ticino	12
Chicago	10
Cagliari	8
Ottawa	8
Redmond	8
Shenyang	8
Benevento	7
Chengdu	7
Wuhan	7
Ankara	6
Helsinki	6
Zhengzhou	6
Auburn Hills	5
Chongqing	5
Amsterdam	4
Berlin	4
Bollate	4
Bologna	4
Copenhagen	4
Hebei	4
Istanbul	4
Los Angeles	4
Napoli	4
Phoenix	4
San Giuliano Milanese	4
Shanghai	4
Stuttgart	4
Villanovafranca	4
Changsha	3
Indiana	3
Jinhua	3
Kuala Lumpur	3
Madrid	3
Moscow	3
New York	3
Salerno	3
Siena	3
Simi Valley	3
Stockholm	3
Taizhou	3
Wenzhou	3
Xian	3
Changchun	2
Chaoyang	2
Cinisello Balsamo	2
Clearwater	2
Florence	2
Folignano	2
Fort Worth	2
Groningen	2
Hangzhou	2
Knoxville	2
Lanzhou	2
Lisbon	2
Milazzo	2
Monza	2
Nanning	2
Naples	2
Ningbo	2
Totale	12629

Salva come PNG Salva come JPEG

Nome	#
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex	205
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect	187
Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats	182
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex	180
New vistas on cannabis use disorder	170
Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2	167
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex	163
Assay of GTPγS binding in autoradiography	162
Cannabis abuse in adolescence and the risk of psychosis: A brief review of the preclinical evidence.	161
Long lasting consequences of cannabis exposure in adolescence.	159
Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin	157
CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour	156
Transcriptomic and Proteomic Analyses of Mouse Cerebellum Reveals Alterations in RasGRF1 Expression Following In Vivo Chronic Treatment with Delta 9-Tetrahydrocannabinol.	156
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid.	155
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice	148
Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats.	145
Adolescent exposure to cannabis as a risk factor for psychiatric disorders	143
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex	141
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism	140
Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine	140
Cannabinoids and opioids share cAMP pathway in rat splenocytes	138
A molecular basis of analgesic tolerance to cannabinoids	138
MeCP2 related studies benefit from the use of CD1 as genetic background	133
null	132
Endocannabinoids and Mental Disorders.	132
Expression and function of the endocannabinoid system in glial cells.	129
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat	129
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function	129
Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine	126
Role of endocannabinoids in regulating drug dependence	124
Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat Part 1: Effects on somatic growth, growth hormone-axis activity and bone mass in the offspring	124
Modulation of rat brain cannabinoid receptors after chronic morphine treatment	123
Cannabinoids and Drugs of abuse	121
CANNABIDIOL/PHYTOCANNABINOIDS: A NEW OPPORTUNITY FOR SCHIZOPHRENIA TREATMENT?	120
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes	118
Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex	117
Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids.	116
The endocannabinoid system and schizophrenia: integration of evidence.	116
Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-) ) show impaired social behaviour but not increased aggression or cognitive inflexibility: evidence of a selective haploinsufficiency gene effect.	115
Sex-dependent vulnerability to cannabis abuse in adolescence	115
Molecular and cellular basis of cannabinoid and opioid interactions	114
Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats.	114
Pertussis toxin inhibits the antinociceptive action of morphine in the rat..	114
Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling	113
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance.	111
Cellular Mechanisms Underlying The Anxiolytic Effect Of Low Doses Of Peripheral D9-Tetrahydrocannabinol In Rats	110
AM630 behaves as a protean ligand at the human cannabinoid CB(2) receptor.	110
Cellular mechanisms underlying the interaction between cannabinoid and opioid system	109
Endocannabinoids and Drug Dependence	109
Sex-dependent changes in brain CB1R expression and functionality and immune CB2R expression as a consequence of maternal deprivation and adolescent cocaine exposure	108
Estrogenic effect of procymidone through activation of MAPK in MCF-7 breast carcinoma cell line	106
Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats.	106
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems	104
Ruolo della via Ras-ERK nella dipendenza ai cannabinoidi	103
Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats	103
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood	102
Cannabidiol inhibits angiogenesis by multiple mechanisms	102
The endocannabinoid system and psychiatric disorders.	101
Neurobiological mechanisms underlying cannabis-induced memory impairment	101
Cannabimimetic activity, binding, and degradation of stearoylethanolamide within the mouse central nervous system	100
Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw	100
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia.	100
Binding studies of dermorphin and its L-form on rat brain opioid receptors.	100
Ruolo emergente del sistema degli endocannabinoidi nelle malattie neuropsichiatriche	100
Chronic treatment with the endocannabinoid anandamide increases cytochrome P450 metabolizing system in the rat	99
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors	99
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain	98
In vivo characterization of the specific cannabinoid receptor antagonist, SR 141716A: behavioral and cellular responses after acute and chronic treatments	98
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain	98
Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects	98
Influence of pertussis toxin on thermic responses to morphine and neurotensin in rats..	98
The psychoactive ingredient of marijuana induces behavioural sensitization	97
Endocannabinoids in the immune system and cancer	97
Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940	97
Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251.	94
Cerebral extract from morphine-tolerant rats shows antiopiate properties in guinea pig ileum bioassay.	94
The phytocannabinoid, delta-9-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce antipsychotic effects	94
Presence and functional regulation of cannabinoid receptors in immune cells	93
Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance - A role for Ras-ERK cascade	93
Central and peripheral components of dermorphin's effect on rat intestinal propulsion in comparison to morphine..	93
Cholera toxin effects on body temperature changes induced by morphine.	93
Cannabinoids as potential new therapy for the treatment of gliomas.	92
Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism.	92
Increase of plasma corticosterone induced by loperamide in rats.	92
Pertussis toxin pretreatment affects opiate/nonopiate and stress-induced analgesia differently.	92
A role of nitric oxide in WIN 55,212-2 tolerance in mice.	91
Presence of a reduced opioid response in interleukin-6 knock out mice	90
Effect on intestinal transit of neurotensin administered intracerebroventricularly to rats.	90
Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophages	89
Cannabinoids, immune system and cytokine network	89
The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro.	89
Regulation of immune functions in rat splenocytes after acute and chronic in vivo treatment with CP-55,940, a synthetic cannabinoid compound.	88
Chronic cannabinoid, CP-55,940, administration alters biotransformation in the rat.	88
Susceptibility to Psychiatric Diseases After Cannabis Abuse in Adolescence: Animal Models	88
In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors	87
Involvement of periaqueductal gray matter in intestinal effect of centrally administered morphine..	87
null	87
Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas.	86
Presence of a reduced opioid response in interleukin-6 knock out mice.	86
Changes in rat spleen cannabinoid receptors after chronic CP-55,940: an autoradiographic study.	86
Totale	11574

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	31022
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	31022

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2017/2018	27	0	0	0	0	0	0	0	0	3	7	11	6
2018/2019	2482	7	130	412	7	5	24	50	200	34	243	561	809
2019/2020	4773	223	181	215	994	331	536	665	586	362	326	79	275
2020/2021	3189	80	340	132	300	192	343	143	248	470	168	295	478
2021/2022	1930	192	203	182	251	58	89	71	94	94	282	149	265
2022/2023	2457	265	165	192	326	157	582	14	381	375	0	0	0
Totale													16765